Literature DB >> 8158876

The role of lymphocytes in the progression of interstitial disease.

F Strutz1, E G Neilson.   

Abstract

Chronic interstitial disease is a major cause of end-stage renal failure. The process is characterized mainly by tubular atrophy and interstitial fibrosis and may be the result of primary or secondary interstitial nephritis. The secondary form attends almost all instances of progressive glomerular and vascular diseases, determining in a large part their outcome. Both forms of interstitial nephritis are initially characterized by the presence of mononuclear infiltrates with the majority being T lymphocytes. The predominance of CD4+ or CD8+ T-cells depends on the underlying cause. Both cell types may lead directly or indirectly to the induction of tubulointerstitial fibrosis. Direct stimulation of fibroblasts to proliferate and produce extracellular matrix may be caused by TGF-beta, IL-4, TNF-alpha, and other fibroblast stimulating factors. Indirect induction of fibroblasts is mediated by stimulation of monocytes/macrophages through IL-2 and IFN-gamma. Furthermore, T cells may directly interact with epithelial cells, leading, for example, to a decrease in type IV collagen production in these cells, thus contributing directly to tubular atrophy. The role of MHC class II expression on tubular epithelial cells in the process of chronic interstitial disease remains to be fully elucidated.

Entities:  

Mesh:

Year:  1994        PMID: 8158876

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  13 in total

1.  Mediators leading to fibrosis - how to measure and control them in tissue engineering.

Authors:  Xd Mu; Ih Bellayr; Tj Walters; Y Li
Journal:  Oper Tech Orthop       Date:  2010-06-01

2.  Association of interleukin (IL)-4 intron-3 and IL-6 -174 G/C gene polymorphism with susceptibility to end-stage renal disease.

Authors:  Rama Devi Mittal; Parmeet Kaur Manchanda
Journal:  Immunogenetics       Date:  2007-01-04       Impact factor: 2.846

Review 3.  Interactions between renal tubules and interstitium.

Authors:  A J Howie; C J Lote
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

4.  PGD2-CRTH2 pathway promotes tubulointerstitial fibrosis.

Authors:  Hideyuki Ito; Xiaoxiang Yan; Nanae Nagata; Kosuke Aritake; Yoshinori Katsumata; Tomohiro Matsuhashi; Masataka Nakamura; Hiroyuki Hirai; Yoshihiro Urade; Koichiro Asano; Masato Kubo; Yasunori Utsunomiya; Tatsuo Hosoya; Keiichi Fukuda; Motoaki Sano
Journal:  J Am Soc Nephrol       Date:  2012-09-20       Impact factor: 10.121

5.  Tumor necrosis factor-alpha production from mononuclear cells in nephrotic syndrome.

Authors:  Ashraf Bakr; Mohamed Shokeir; Farha El-Chenawi; Fatma El-Husseni; Ashraf Abdel-Rahman; Rasha El-Ashry
Journal:  Pediatr Nephrol       Date:  2003-04-18       Impact factor: 3.714

6.  Interstitial myofibroblasts: predictors of progression in membranous nephropathy.

Authors:  I S Roberts; C Burrows; J H Shanks; M Venning; L J McWilliam
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

7.  Mast cells: the forgotten cells of renal fibrosis.

Authors:  I S Roberts; P E Brenchley
Journal:  J Clin Pathol       Date:  2000-11       Impact factor: 3.411

8.  Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice.

Authors:  Kent Doi; Koji Okamoto; Kousuke Negishi; Yoshifumi Suzuki; Akihide Nakao; Toshiro Fujita; Akiko Toda; Takehiko Yokomizo; Yoshihiro Kita; Yasuyuki Kihara; Satoshi Ishii; Takao Shimizu; Eisei Noiri
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 9.  Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications.

Authors:  José M López-Novoa; Ana B Rodríguez-Peña; Alberto Ortiz; Carlos Martínez-Salgado; Francisco J López Hernández
Journal:  J Transl Med       Date:  2011-01-20       Impact factor: 5.531

10.  Adenosine A2A receptor: a target for regulating renal interstitial fibrosis in obstructive nephropathy.

Authors:  Hang Xiao; Hai-Ying Shen; Wei Liu; Ren-Ping Xiong; Ping Li; Gang Meng; Nan Yang; Xing Chen; Liang-Yi Si; Yuan-Guo Zhou
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.